Onset of severe perianal disease in Crohn's disease under treatment with infliximab: Successful treatment with adalimumab and setons drainage
β Scribed by Antonio Tursi; Alfredo Papa; Michele Maiorano
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 163 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: We sought to characterize perianal disease and its treatment in pediatric patients newly diagnosed with crohn's disease. ## Methods: Data were obtained from the pediatric inflammatory bowel disease (ibd) collaborative group registry, a prospective, multicenter observational registr
## Background: Natalizumab, a humanized monoclonal igg(4) antibody to alpha4 integrin, was investigated as a treatment of active crohn's disease (cd). the safety of natalizumab given in combination with infliximab has not previously been studied. ## Methods: Seventy-nine adult patients with activ